Trymox vet 150 mg/ml injektioneste, suspensio Suomi - suomi - Fimea (Suomen lääkevirasto)

trymox vet 150 mg/ml injektioneste, suspensio

univet ltd. - amoxicillin trihydrate - injektioneste, suspensio - 150 mg/ml - amoksisilliini

Nemavet vet 50 mg/g jauhe Suomi - suomi - Fimea (Suomen lääkevirasto)

nemavet vet 50 mg/g jauhe

univet ltd. - fenbendazole - jauhe - 50 mg/g - fenbendatsoli

Ubroseal vet 2.6 g intramammaarisuspensio Suomi - suomi - Fimea (Suomen lääkevirasto)

ubroseal vet 2.6 g intramammaarisuspensio

univet ltd. - bismuth subnitrate - intramammaarisuspensio - 2.6 g - muut vetimien ja utareiden hoitoon tarkoitetut valmisteet

Chloromed vet 150 mg/g esisekoite lääkerehua varten Suomi - suomi - Fimea (Suomen lääkevirasto)

chloromed vet 150 mg/g esisekoite lääkerehua varten

univet ltd. - chlortetracycline hydrochloride - esisekoite lääkerehua varten - 150 mg/g - klooritetrasykliini

Sunitinib Vivanta 50 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

sunitinib vivanta 50 mg kapseli, kova

vivanta generics s.r.o. - sunitinib malate - kapseli, kova - 50 mg - sunitinibi

Sunitinib Vivanta 37.5 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

sunitinib vivanta 37.5 mg kapseli, kova

vivanta generics s.r.o. - sunitinib malate - kapseli, kova - 37.5 mg - sunitinibi

Sunitinib Vivanta 25 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

sunitinib vivanta 25 mg kapseli, kova

vivanta generics s.r.o. - sunitinib malate - kapseli, kova - 25 mg - sunitinibi

Sunitinib Vivanta 12.5 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

sunitinib vivanta 12.5 mg kapseli, kova

vivanta generics s.r.o. - sunitinib malate - kapseli, kova - 12.5 mg - sunitinibi

Sunitinib Accord Euroopan unioni - suomi - EMA (European Medicines Agency)

sunitinib accord

accord healthcare s.l.u. - sunitinibi - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiset aineet - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Sutent Euroopan unioni - suomi - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinibi - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiset aineet - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.